Dasatinib may also inhibit c-Kit in triple negative breast cancer cell lines.
Article Details
- CitationCopy to clipboard
Dizdar O, Dede DS, Bulut N, Altundag K
Dasatinib may also inhibit c-Kit in triple negative breast cancer cell lines.
Breast Cancer Res Treat. 2008 Jan;107(2):303. Epub 2007 Mar 10.
- PubMed ID
- 17351742 [ View in PubMed]
- Abstract
Not Available
DrugBank Data that Cites this Article
- Drug Targets
Drug Target Kind Organism Pharmacological Action Actions Dasatinib Mast/stem cell growth factor receptor Kit Protein Humans YesAntagonistDetails